Differential expression and origin of membrane-type 1 and 2 matrix metalloproteinases (MT-MMPS)in association with MMP2 activation in injured human livers

American Journal of Pathology

Volumn 153, Issue 3, 1998, Pages 945-954

  Théret, Nathalie ^a   Musso, Orlando ^a   L'Helgoualc'h, Annie ^a   Campion, Jean Pierre ^a   Clément, Bruno ^a  

^a UNIVERSITÉ DE RENNES 1   (France)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGENASE; GELATINASE A; MESSENGER RNA;

ARTICLE; COLON ADENOCARCINOMA; CONTROLLED STUDY; ENZYME LOCALIZATION; HUMAN; HUMAN TISSUE; IN SITU HYBRIDIZATION; LIVER CELL CARCINOMA; LIVER INJURY; LIVER METASTASIS; LIVER TUMOR; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA ANALYSIS;

EID: 0031708377     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)65636-2     Document Type: Article

References (44)

1. Matnsian LM: Metalloproteinases and their inhibitors in matrix remodelling. Trends Genet 1990, 6:121-125
2. Stetler-Stevenson WG, Aznavoorian S, Liotta LA: Tumor cell interactions with the extracellular matrix during invasion and metastasis. Annu Rev Cell Biol 1993, 9:541-573
3. Birkedal-Hansen H: Proteolytic remodeling of extracellular matrix. Curr Opin Cell Biol 1995, 7:728-735
4. Corcoran ML, Hewitt RE, Kleiner DE Jr, Stetler-Stevenson WG: MMP-2: expression, activation and inhibition. Enzyme Protein 1996, 49:7-19
5. Yu AE, Hewitt RE, Kleiner DE, Stetler-Stevenson WG: Molecular regulation of cellular invasion: role of gelatinase A and TIMP-2. Biochem Cell Biol 1996, 74:823-831
6. Sato H, Takino T, Okada Y, Cao J, Shinagawa A, Yamamoto E, Seiki M: A matrix metalloproteinase expressed on the surface of invasive tumor cells. Nature (Lond) 1994, 370:61-65
7. Yamamoto M, Mohanam S, Sawaya R, Fuller GN, Seiki M, Sato H, Gokaslan ZL, Liotta LA, Nicolson GL, Rao JS: Differential expression of membrane-type matrix metalloproteinase and its correlation with gelatinase activation in human malignant brain tumors in vivo and in vitro. Cancer Res 1996, 56:384-392
8. Yoshizaki T, Sato H, Maruyama Y, Murono S, Furukawa M, Park C, Seiki M: Increased expression of membrane type 1-matrix metalloproteinase in head and neck carcinoma. Cancer 1997, 79:139-144
9. Ueno H, Nakamura H, Inoue M, Imai K, Noguchi M, Sato H, Seiki M, Okada Y: Expression and tissue localization of membrane-types 1, 2, and 3 matrix metalloproteinases in human invasive breast carcinomas. Cancer Res 1997, 57:2055-2060
10. Mori M, Mimori K, Shiraishi T, Fujie T, Baba K, Kusumoto H, Haraguchi M, Ueo H, Akiyoshi T: Analysis of MT1-MMP and MMP2 expression in human gastric cancer. Int J Cancer 1997, 74:316-321
11. Will H, Hinzmann B: cDNA sequence and mRNA tissues distribution of a novel human matrix metalloproteinase with a potential transmembrane segment. Eur J Biochem 1995, 231:602-608
12. Takino T, Sato H, Shinagawa A, Seiki M: Identification of the second membrane-type matrix metalloproteinase (MT-MMp-2) gene from a human placenta cDNA library. J Biol Chem 1995, 270: 23013-23020
13. Puente XS, Pendas AM, Llano E, Velasco G, Lopez-Otin C: Molecular cloning of a novel membrane-type matrix metalloproteinase from a human breast carcinoma. Cancer Res 1996, 56:944-949
14. Kolkenbrock H, Hecker-Kia A, Orgel D, Ulbrich N, Will H: Activation of progelatinase A and progelatinase A/TIMP-2 complex by membrane-type matrix metalloproteinase. J Biol Chem 1997, 378:77-76
15. Tanaka M, Sato H, Takino T, Iwata K, Inoue M, Seiki M: Isolation of a mouse MT2-MMP gene from a lung cDNA library and identification of its product. FEBS Lett 1997, 402:219-222
16. Milani S, Herbst H, Schuppan D, Grappone C, Pelligrini G, Pinzani M, Casini A, Calabro A, Ciancio G, Stefanini F, Burroughs AK, Surrenti C: Differential expression of matrix metalloproteinase-1 and -2 genes in normal and fibrotic human liver. Am J Pathol 1994, 144:528-537
17. Nakatsukasa H, Ashida K, Higsahi T, Ohgughi S, Tsuboi S, Hino N, Nouso K, Urabe Y, Kinugasa N, Yoshida K, Uematsu S, Ishizaki M, Kobayashi Y, Tsusi T: Cellular distribution of transcripts for tissue inhibitor of metalloproteinases 1 and 2 in human hepatocellular carcinomas. Hepatology 1996, 24:82-88
18. Osaki I, Yamamoto K, Mizuta T, Setoguchi Y, Morito F, Sakai T: Detection of matrix metalloproteinase gene expression by reverse transcription polymerase chain reaction in human hepatocellular carcinomas. Int Hepatol Commun 1996, 6:36-42
19. Théret N, Musso O, Campion JP, Turlin B, Loréal O, L'Helgoualc'h A, Clément B: Overexpression of matrix metalloproteinase-2 and tissue inhibitor of matrix metalloproteinase-2 in liver from patients with gastrointestinal adenocarcinoma and no detectable metastasis. Int J Cancer 1997, 74:1-7
20. Musso O, Théret N, Campion JP, Turlin B, Milani S, Grappone C, Clément B: In situ detection of matrix metalloproteinase-2 (MMP2), and the metalloproteinase inhibitor TIMP2 transcripts in human primary hepatocellular carcinoma, and in liver metastasis. J Hepatol 1997, 26:593-605
21. Grigioni WF, Garbisa S, D'Errico A, Baccarini P, Stetler-Stevenson WG, Liotta LA, Mancini AM: Evaluation of hepatocellular carcinoma aggressiveness by a panel of extracellular matrix antigens. Am J Pathol 1991, 138:647-654
22. Arii S, Tanaka J, Yamazoe Y, Minematsu S, Morino T, Fujita K, Maetani S Tobe T: Predictive factors for intrahepatic recurrence of hepatocellular carcinoma after partial hepatectomy. Cancer 1992, 69:913-919
23. Yamamoto H, Itoh F, Adachi Y, Sakamoto H, Adachi M, Hinoda Y, Imai K: Relation of enhanced secretion of active matrix metalloproteinases with tumor spread in human hepatocellular carcinoma. Gastroenterology 1997, 112:1290-1296
24. Théret N, Musso O, L'Helgoualc'h A, Clément B: Activation of matrix metalloproteinase-2 from hepatic stellate cells requires interactions with hepatocytes. Am J Pathol 1997, 150:51-58
25. Arthur MJP, Friedman SL, Roll FJ, Bissell DM: Lipocytes from normal rat liver release a neutral metalloproteinase that degrades basement membrane (type IV) collagen. J Clin Invest 1989, 84:1076-1085
26. Emonard H, Remade AG, Noël AC, Grimaud JA, Stetler-Stevenson WG, Foidart JM: Tumor cell surface-associated binding site for the M, 72,000 type IV collagenase. Cancer Res 1992, 52:5845-5848
27. Young TN, Pizzo SV, Stack MS: A plasma membrane-associated component of ovarian adenocarcinoma cells enhances the catalytic efficiency of matrix metalloproteinase-2. J Biol Chem 1995, 270:999-1002
28. Yu M, Sato H, Seiki M, Thompson EW: Complex regulation of membrane-type matrix metalloproteinase expression and matrix metalloproteinase-2 activation by concanavalin A in MDA-MB-231 human breast cancer cells. Cancer Res 1995, 55:3272-3277
29. Takino T, Sato H, Yamamoto E, Seiki M: Cloning of a human gene potentially encoding a novel matrix metalloproteinase having a C-termmal transmembrane domain. Gene 1995, 155:293-298
30. Edmondson H, Steiner P: Primary carcinoma of the liver: a study of 100 cases among 48900 necropsies. Cancer 1954, 7:462-503
31. Loréal O, Levavasseur F, Fromaget C, Gros D, Guillouzo A, Clément B: Cooperation of Ito cells and hepatocytes in the deposition of an extracellular matrix in vitro. Am J Pathol 1993, 143:538-544
32. Guguen-Guillouzo C, Campion JP, Brissot P, Glaise D, Bourel M, Guillouzo A: High-yield preparation of isolated human adult hepatocytes by enzymatic perfusion of the liver. Cell Biol Int Rep 1982, 6:625-628
33. Chan YL, Gutell R, Noller HF, Wool IG: The nucleotide sequence of a rat 18S ribosomal ribonucleic acid gene and a proposal for the secondary structure of 18S ribosomal ribonucleic acid. J Biol Chem 1984, 259:224-230
34. Chomczynski P, Sacchi N: Single-step method of MRNA isolation by guanidini um thiocyanate phenol chloroform extraction. Anal Biochem 1987, 162:156-169
35. Liétard J, Musso O, Théret N, L'Helgoualc'h A, Campion JP, Yamada Y, Clément B: SP1-mediated transactivation of LamC1 promoter and coordinated expression of laminin γ1 and SP1 mRNA in human hepatocarcinomas. Am J Pathol 1997, 151:1663-1672
36. Welgus HG, Campbell EJ, Curry JD, Eisen AZ, Senior RM, Wilhelm SM Goldberg GI: Neutral metalloproteinases produced by human mononuclear phagocytes. J Clin Invest 1990, 86:1496-1502
37. Davies B, Miles DW, Happerfield LC, Naylor MS, Bobrow LG, Rubens RD Balkwill FR: Activity of type IV collagenases in benign and malignant breast disease. Br J Cancer 1993, 67:1126-1131
38. Tokuraku M, Sato H, Murakami S, Okada Y, Watanabe Y, Seiki M: Activation of the precursor of gelatinase A/72 kd type IV collagenase/ MMP2 in lung carcinomas correlates with the expression of membrane-type matrix metalloproteinase (MT-MMP) and with lymph node metastasis. Int J Cancer 1995, 64:355-359
39. Nomura H, Sato H, Seiki M, Mai M, Okada Y: Expression of membrane-type matrix metalloproteinase in human gastric carcinomas. Cancer Res 1995, 55:3263-3266
40. Yamamoto M, Mohanam S, Sawaya R, Fuller GN, Seiki M, Sato H, Gokaslan ZL, Liotta LA, Nicolson GL, Rao JS: Differential expression of membrane-type matrix metalloproteinase and its correlation with gelatinase activation in human malignant brain tumors in vivo and in vitro. Cancer Res 1996, 56:384-392
41. Yoshizaki T, Sato H, Maruyama Y, Murono S, Furukawa M, Park C, Seiki M: Increased expression of membrane type 1-matrix metalloproteinase in head and neck carcinoma. Cancer 1997, 79:139-144
42. Takahara T, Furui K, Funaki J, Nakayama Y, Itoh H, Miyabayashi C, Sato H, Seiki M, Ooshima A, Watanabe A: Increased expression of matrix metalloproteinase-II in experimental liver fibrosis in rats. Hepatology 1995, 21:787-795
43. Demetris AJ, Seaberg EC, Wennerberg A, lonellie J, Michalopoulos G: Ductular reaction after submassive necrosis in human: special emphasis on analysis of ductular hepatocytes. Am J Pathol 1996, 149:439-448
44. Kinoh H, Sato H, Tsunezuka Y, Takino T, Kawashima A, Okada Y, Seiki M: MT-MMP, the cell surface activator of proMMP-2 (pro-gelatinase A) is expressed with its substrate in mouse tissue during embryogenesis. J Cell Sci 1996, 109:953-958